With a new CEO at the helm, the Laboratory for Advanced Medicine (LAM) is preparing for the launch of its first liquid biopsy—a blood test designed to detect early-stage liver cancer, expected to win approvals starting in China this year . . .
The post At Laboratory for Advanced Medicine, New CEO Sharpens Commercial Focus appeared first on GEN – Genetic Engineering and Biotechnology News.
